The controlled drugs listed in the first column are presumed to be for supply at and over the amount, level, or quantity listed in the second column.
| 25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) | | 25 milligrams or 25 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| 25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) | | 25 milligrams or 25 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| 25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) | | 25 milligrams or 25 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| Amphetamine | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| Morphine | | 5 grams, whether or not contained in a substance, preparation, or mixture |
| Cocaine | | half a gram, whether or not contained in a substance, preparation, or mixture |
| Heroin | | half a gram, whether or not contained in a substance, preparation, or mixture |
| Ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone) | | 10 grams, whether or not contained in a substance, preparation, or mixture |
| Lysergide | | two and a half milligrams or 25 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| DOB (2-amino-1-(4-bromo-2,5-dimethoxyphenyl)propane) (also known as bromo-DMA) | | 100 milligrams or 25 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| MDMA (2-methylamino-1-(3,4-methylenedioxyphenyl)propane) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| N-ETHYL MDA (2-ethylamino-1-(3,4-methylenedioxyphenyl)propane) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| MDA (2-amino-1-(3,4-methylenedioxyphenyl)propane) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| Tetrahydrocannabinol (as described in Schedule 2) | | 250 milligrams, whether or not contained in a substance, preparation, or mixture |
| Any cannabis preparation (as described in Schedule 2) | | 5 grams or 100 cigarettes containing the drug |
| Cannabis plant (as described in Schedule 3) | | 28 grams or 100 cigarettes containing the drug |
| BZP (1-benzylpiperazine or A2 benzylpiperazine or N-benzylpiperazine (1-benzyl-1,4-diazacyclohexane)) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| TFMPP (1-(3-trifluoromethylphenyl)piperazine or N-(3-trifluoromethylphenyl)piperazine) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| pFPP (1-(4-fluorophenyl)piperazine) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| MeOPP (1-(4-methoxyphenyl)piperazine) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| mCPP (1-(meta-chlorophenyl)piperazine) or 1-(3-chlorophenyl)piperazine) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| MBZP (1-methyl-4-benzylpiperazine) | | 5 grams or 100 flakes, tablets, capsules, or other drug forms each containing some quantity of the drug |
| Methamphetamine | | 5 grams, whether or not contained in a substance, preparation, or mixture |
| Ephedrine | | 10 grams, whether or not contained in a substance, preparation, or mixture |
| Pseudoephedrine | | 10 grams, whether or not contained in a substance, preparation, or mixture |
Schedule 5 clause 1 25B-NBOMe: inserted, on 22 December 2016, by clause 4 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).
Schedule 5 clause 1 25C-NBOMe: inserted, on 22 December 2016, by clause 4 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).
Schedule 5 clause 1 25I-NBOMe: inserted, on 22 December 2016, by clause 4 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).
Schedule 5 clause 1 Amphetamine: inserted, on 9 September 2005, by clause 4 of the Misuse of Drugs (Presumption of Supply—Amphetamine) Order 2005 (SR 2005/174).
Schedule 5 clause 1 Ketamine: inserted, on 1 December 2010, by clause 3 of the Misuse of Drugs (Presumption of Supply—Ketamine) Order 2009 (SR 2009/256).
Schedule 5 clause 1 BZP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 TFMPP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 pFPP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 MeOPP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 mCPP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 MBZP: inserted, on 1 April 2008, by section 5 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 Ephedrine: inserted, on 8 September 2011, by section 11 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).
Schedule 5 clause 1 Pseudoephedrine: inserted, on 8 September 2011, by section 11 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).